GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Toleranzia AB (OSTO:TOL) » Definitions » Cash Receipts from Loans

Toleranzia AB (OSTO:TOL) Cash Receipts from Loans


View and export this data going back to 2015. Start your Free Trial

What is Toleranzia AB Cash Receipts from Loans?

Cash Receipts from Loans only applicable to companies reporting Cash Flow from Operations in direct method.


Toleranzia AB Business Description

Traded in Other Exchanges
N/A
Address
Arvid Wallgrens backe 20, 8th floor, Gothenburg, SWE, 413 46
Toleranzia AB is a Swedish biotechnology company. It develops drugs that harness the power of the immune system to treat autoimmune orphan diseases. The company uses its tolerance technology for drug development, which is based on the identification of disease-specific proteins that are developed into biological drugs, specific to each autoimmune disease. Its drug development pipeline includes TOL2, which is being developed for the treatment of autoimmune orphan disease myasthenia gravis, and TOL3, being developed for another indication in autoimmune orphan diseases, ANCA vasculitis.